BRIAN CHARLES SANDERS

Allopathic & Osteopathic Physicians|Otolaryngology YONKERS, NY NPI 1730536749

General Payments — all program years on this page

$4,066.56

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 168
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $991.87 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $991.8740

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $762.2219
2022 $924.0541
2023 $1,388.4268
2024 $991.8740

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087191211 Novartis Pharmaceuticals Corporation $24.93 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087191217 Novartis Pharmaceuticals Corporation $20.24 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087191221 Novartis Pharmaceuticals Corporation $22.95 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087191225 Novartis Pharmaceuticals Corporation $24.38 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087191237 Novartis Pharmaceuticals Corporation $24.41 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116179232 GlaxoSmithKline, LLC. $24.01 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116251540 GlaxoSmithKline, LLC. $30.33 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116264548 GlaxoSmithKline, LLC. $21.40 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116391654 GlaxoSmithKline, LLC. $8.57 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116408859 GlaxoSmithKline, LLC. $32.19 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116442961 GlaxoSmithKline, LLC. $30.88 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116539298 GlaxoSmithKline, LLC. $30.04 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116575532 GlaxoSmithKline, LLC. $30.88 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116596271 GlaxoSmithKline, LLC. $23.00 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116596993 GlaxoSmithKline, LLC. $15.52 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124717116 Grifols USA, LLC $19.24 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124717118 Grifols USA, LLC $17.83 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124717120 Grifols USA, LLC $22.43 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126623302 kaleo, Inc. $18.47 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127505789 Hikma Pharmaceuticals USA $18.35 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127505801 Hikma Pharmaceuticals USA $21.41 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127505875 Hikma Pharmaceuticals USA $50.50 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131616490 PFIZER INC. $19.79 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131616494 PFIZER INC. $21.74 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131617159 PFIZER INC. $24.86 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131617163 PFIZER INC. $24.70 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131617167 PFIZER INC. $22.45 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131617171 PFIZER INC. $23.54 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137667966 Takeda Pharmaceuticals U.S.A., Inc. $24.53 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139627824 GENZYME CORPORATION $30.00 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139627844 GENZYME CORPORATION $30.00 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139627848 GENZYME CORPORATION $33.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139627862 GENZYME CORPORATION $33.00 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139627866 GENZYME CORPORATION $20.65 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139627888 GENZYME CORPORATION $30.00 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139627924 GENZYME CORPORATION $30.00 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139627932 GENZYME CORPORATION $31.43 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142177974 Optinose US, Inc. $21.32 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142178006 Optinose US, Inc. $20.84 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148105855 Inspire Medical Systems, Inc. $18.06 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.